Non-invasive diagnosis is a procedure of identifying a disease
without or with minimal incision of the body. These methods involve
different techniques such as identifying genetic structure,
biomarkers, changes in molecular biology, along with imaging
technologies. Cancer is a disease related to genetic alteration of
the cells and therefore causing uncontrolled growth and forming tumor
like structure. Imaging is the preferred method of cancer detection
but cannot have genetic access; on the other hand biopsies which have
genetic access are complicated and difficult to perform repetitively
during the course of cancer diagnosis and therapy. Therefore newer
techniques developed in lines with non invasive diagnosis such as
molecular diagnosis, serum based immunoassays and chemical tests to
identify chemical components in the body especially from blood and
urine. All these procedures are performed either with non-surgical or
minimal surgical procedures; therefore these non-invasive cancer
diagnostic techniques are becoming more and more popular among
healthcare practitioners.
Report Overview @
https://www.transparencymarketresearch.com/noninvasive-cancer-diagnostics-market.html
According to WHO and World Cancer Report, by 2020, new cancer cases
will be around 15 million annually, of which breast, ovarian and GI
cancer are expected to be most commonly occurring types. Cancer is
the disease condition which has highest prevalence rate all over the
world and causes considerable amount of burden on economies.
Therefore early and accurate detection of cancer along with
monitoring its growth at later stages is very critical. Though
invasive types of cancer diagnoses are accurate in early stages, the
same procedures cannot be used for monitoring growth of cancer at
different stages since surgeries are required for these types of
diagnoses. The non-invasive cancer diagnosis has growth potential all
across the world; however developed countries such as USA, UK, Japan,
Canada and some emerging economies such as India, China, Brazil and
Russia are observed to experience highest growth in demand for
non-invasive cancer diagnostic.
Non-invasive cancer diagnostics market can be segmented by various
categories such as by region, by techniques and according to
different types of oncological conditions. Geographically Non
invasive cancer diagnostic market is segmented in four regions mainly
North America, Europe, Asia-Pacific and Rest of the World. Out of all
these four geographies, the contribution from North America is
highest followed by Europe, Asia-Pacific and Rest of the World.
Higher awareness among healthcare fraternity, availability of
advanced diagnostic technologies in North America and European
countries may help sustain the growth of non-invasive cancer
diagnostics in these regions.
Download Report Brochure @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=8197
On the other hand increasing incidences and prevalence of cancer and
rising awareness in Asia-Pacific countries have created demand for
non-invasive cancer diagnostic market sizably. On the basis of
techniques for non invasive cancer diagnosis, market can be segmented
in molecular biology, serum immunoassay and clinical component
identification in blood and serum. As different types of cancer
causes different molecular, biological and chemical changes in body
therefore this market can be divided according to cancer types such
as blood cancer, lung cancer, breast cancer, ovarian cancer, skin
cancer and others.
There are many companies operating in non invasive cancer diagnostic
in market out of them Roche Diagnostics, Quidel, Immunicon
Corporation, Compugen, DiagnoCure, Abbott Molecular, GE Healthcare,
Precision Therapeutics, Affymetrix Inc, , Digene Corporation are the
major contributor in this market. Introduction of various advanced
technologies such as Cologuard by Exact Sciences will pave the way
for the future of this market. In March 2014, the U.S. FDA approved
the product for non-invasive testing of colorectal cancer which is
one of the most frequently occurring types of cancer observed in
recent years.
Pre-Book Full Report @
https://www.transparencymarketresearch.com/checkout.php?rep_id=8197<ype=S
About Us
Transparency Market Research (TMR) is a market intelligence company,
providing global business information reports and services. Our
exclusive blend of quantitative forecasting and trends analysis
provides forward-looking insight for thousands of decision makers.
TMR’s experienced team of analysts, researchers, and consultants,
use proprietary data sources and various tools and techniques to
gather, and analyze information. Our business offerings represent the
latest and the most reliable information indispensable for businesses
to sustain a competitive edge.
Each TMR syndicated research report covers a different sector - such
as pharmaceuticals, chemicals, energy, food & beverages,
semiconductors, med-devices, consumer goods and technology. These
reports provide in-depth analysis and deep segmentation to possible
micro levels. With wider scope and stratified research methodology,
TMR’s syndicated reports strive to provide clients to serve their
overall research requirement.
US Office Contact
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email:
sales@transparencymarketresearch.com
Website:
https://www.transparencymarketresearch.com
No comments:
Post a Comment